Cargando…
Feasibility of virtual Alzheimer's biomarker disclosure: Findings from an observational cohort
INTRODUCTION: Increased availability of Alzheimer's disease (AD) biomarker tests provides older adults with opportunities to seek out and learn results. We evaluated the feasibility of virtually returning AD biomarker results. METHODS: Trained study clinicians disclosed amyloid positron emissio...
Autores principales: | Erickson, Claire M., Chin, Nathaniel A., Rosario, Hannah L., Peterson, Amanda, Johnson, Sterling C., Clark, Lindsay R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382796/ https://www.ncbi.nlm.nih.gov/pubmed/37521522 http://dx.doi.org/10.1002/trc2.12413 |
Ejemplares similares
-
Virtual disclosure of preclinical Alzheimer's biomarkers: Preliminary experiences
por: Erickson, Claire M., et al.
Publicado: (2021) -
Research Participant Interest in Alzheimer’s Disease Biomarker Disclosure
por: Erickson, Claire, et al.
Publicado: (2020) -
Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know
por: Erickson, Claire M., et al.
Publicado: (2021) -
Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society
por: Erickson, Claire M., et al.
Publicado: (2022) -
Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing
por: Ketchum, Fred B., et al.
Publicado: (2022)